HEALTH EvolveImmune Therapeutics to Present Update on Lead Asset EVOLVE104 and New Data for EVOLVE T Cell Engager Platform at 2026 AACR Annual Meeting Tuesday, April 14, 2026 · evolveimmune therapeutics Advertisement Read Original Article → Related Dispatches [CA] · Jul 30 Leaked health care report shows Lloydminster services 'struggling to keep up': Sask. NDP [US] · Jul 30 STAT+: Tracking the FDA expert review of Replimune’s melanoma treatment [CA] · Jul 30 Family of N.S. mass shooting victim training educators on youth mental health, resilience